Peter Kreiner

Senior Scientist

Peter  Kreiner's photo


Office: Heller-Brown Building 250
Phone: 781-736-3945
Brandeis Directory


Prescription drug misuse, abuse, and diversion, with a particular emphasis on state prescription drug monitoring programs and the use of their data for public health surveillance and evaluation. Program evaluation, especially in substance abuse prevention and treatment; Interagency and social network analysis. Small geographic area measures and models


  • University of Southern California
  • Princeton University

Peter Kreiner

Senior Scientist


Peter Kreiner, Ph.D., is a Senior Scientist at the Schneider Institute for Health Policy, Brandeis University. His research encompasses five overlapping areas: (1) prescription drug monitoring programs, methods and tools for evaluating them and identifying best practices; (2) uses of prescription drug monitoring program data for public health surveillance and evaluation; (3) inter-organizational and interpersonal networks, and their roles in health services coordination and, more generally, state and community health infrastructures; (4) diffusion of innovation, including the adoption of evidence-based programs by substance abuse prevention and treatment agencies; and (5) small geographic area measures and models of health-related and social problems, risk for such problems, and protection from such problems.


  • Weiner, SG, Baker, O, Rogers, AF, Garner, C, Nelson, LS, Kreiner, PW, and Schuur, JD.. "Opioid prescriptions by specialty in Ohio, 2010-2014." Pain Medicine (2017). (forthcoming)
  • Young, L, Kreiner, P, and Panas, L.. "Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group." Pain Medicine (2017). (forthcoming)
  • Strickler GK, Kreiner PW, Halpin JF, Doyle E, and Paulozzi LJ.. "Opioid prescribing behaviors – Prescription Behavior Surveillance System, 11 states, 2010 – 2016.." MMWR Surveillance Summaries 69. 1 (2020): 1-14.
  • Gail K. Strickler, Kun Zhang, John F. Halpin, Amy S.B. Bohnert, Grant T. Baldwin, Peter W. Kreiner. "Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing." Drug and Alcohol Dependence 199. (2019): 1-9.
  • Kreiner, Peter. "Utilization of PDMPs in Managed Care: How Can PDMPs Support PRR Programs?." Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting. Boston, MA. April 24, 2018.
  • Kreiner, Peter. "“Trajectories of PDMP-based Patient Risk Indicators and Likelihood of Overdose Death.”." Rx Abuse and Heroin Summit. Atlanta, GA. April 9, 2019.
  • Strickler GK, Zhang K, Halpin JM, Bohnert ASB, Baldwin G, and Kreiner PW.. "Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.." Drug and Alcohol Dependence 199. (2019): 1-9.
  • Becker, WC, Fenton, BT, Brandt, CA, Doyle, EL, Francis, J, Goulet, JL, Moore, BA, Torrise, V, Kerns, RD, and Kreiner, PW. "Multiple sources of prescription payment and risky opioid therapy among veterans." Medical Care 55. 7, S1 (2017): S33-S36.
  • Kreiner, PW, Strickler, GK, Undurraga, EA, Torres, ME, Nikitin, RV, and Rogers, A.. "Validation of prescriber risk indicators obtained from prescription drug monitoring program data." Drug and Alcohol Dependence 173. (2017): S31-S38.
  • Kreiner, Peter. "PDMP Policy Developments: Evaluating Prescriber-Use Mandates." Rx and Heroin Abuse Summit. Atlanta, GA. April 18, 2017.
  • Thomas CP, Doyle E, Kreiner P, Jones CM, Dubenitz J, Horan A, and Stein B. "Prescribing patterns of buprenorphine waivered physicians." Drug and Alcohol Dependence 181. (2017): 213-218.
  • Kreiner, Peter. "A Validation Study of Prescriber Risk Measures from the Prescription Behavior Surveillance System." Rx and Heroin Abuse Summit. Atlanta, GA. March 29, 2016.
  • Kreiner, Peter. Geographic associations between heroin- and prescription opioid-related overdose death rates and PDMP-based risk indicators in Kentucky counties, 2011-2014. Prepared with Deloitte, Inc. for Centers for Disease Control and Prevention: 2016.
  • Kolodny, A., Courtwright, D.T., Hwang, C.S., Kreiner, P., Eadie, J.L., Clark, T. W., and Alexander, G.C.. "The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction.." Annual Review of Public Health 36. (2015): 559-574.
  • Kreiner, Peter. "PDMP Data as a Surveillance and Evaluation Tool: Preliminary Findings, Emerging Trends, and Pitfalls." SAMHSA Prescription Drug Monitoring Program - Electronic Health Record Interoperability Grantee Meeting. Silver Spring, MD. January 22, 2015.
  • Kreiner, Peter. "Using Prescription Drug Monitoring Program Data for Early Warning, Evaluation, and Prevention: Prevention Strategies to Address Opioid Drug Abuse." SAMHSA's Prevention Day, CADCA Leadership Forum. Arlington, VA. February 2, 2015.
  • Paulozzi, LJ, Strickler, GK, Kreiner, PW, and Koris, CM. "Controlled substance prescribing patterns – Prescription Behavior Surveillance System, Eight States, 2013." Morbidity and Mortality Weekly Report, Surveillance Summaries 64. 9 (2015): 1-14.
  • Kreiner, Peter. "Measuring doctor/pharmacy shopping using prescription drug monitoring program data." Food and Drug Administration Public Meeting on the Postmarketing Requirements for the Class-Wide Extended-Release/Long-Acting Opioid Analgesics. Silver Spring, MD. May 19, 2014.
  • Kreiner, Peter. "Mitigating the Epidemic: Prescription Drug Monitoring Programs.." Utah Poison Control Center 60th Anniversary Symposium. Salt Lake City, UT. October 2, 2014.
  • Kreiner, Peter. "Outcomes from the Prescription Behavior Surveillance System." Prescription Drug Monitoring Program National Meeting. Washington, DC. September 24, 2014.
  • Kreiner, Peter. "Prescription Behavior Surveillance System: The value and applications of de- identified PDMP data in public health surveillance.." Rx Abuse Summit. Atlanta, GA. April 23, 2014.
  • Kreiner, Peter. "The Prescription Behavior Surveillance System: Applications of de-identified PDMP data in public health surveillance." PDMP National Meeting on Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse. Washington, DC. June 4, 2014.
  • Kreiner, Peter. "The Prescription Behavior Surveillance System: Selected Data from Washington’s PDMP." Washington State’s Prescription Drug Monitoring Program Implementation Forum. Seattle, WA (webinar). October 30, 2014.
  • Kreiner, Peter. "Using prescription drug monitoring program data for early warning, evaluation, and prevention." SAMHSA Prescription Drug Abuse Policy Academy. Silver Spring, MD. August 12, 2014.
  • Thomas, C.P., Kim, M., Nikitin, R.V., Kreiner, P., Clark, T., and Carrow, G.. "Physician response to unsolicited prescription drug monitoring program reports in Massachusetts.." Pharmacoepidemiology and Drug Safety 23. 9 (2014): 950-957.
  • Kreiner, P. Nikitin, R., & Shields, T.P.. Bureau of Justice Assistance Prescription Drug Monitoring Program Performance Measures Report: January, 2009 through June, 2012. Washington, DC U.S. Department of Justice, Bureau of Justice Assistance: 2013.
  • Kreiner, Peter. "How prescription drug monitoring programs can help address the opioid epidemic." Workers' Compensation Research Institute Annual Conference. Cambridge, MA. February 27, 2013.
  • Thomas, C., Kim, M., Kelleher, S., Nikitin, R., Kreiner, P., McDonald, A., & Carrow, G.. "Early experience with electronic prescribing of controlled substances in a community setting." Journal of the American Medical Informatics Association doi: 10.1136/amiajnl-2012-001499. (2013).
  • Clark, T., Eadie, J., Kreiner, P., & Strickler, G.. Prescription Drug Monitoring Programs: An Assessment of the Evidence for Best Practices. Washington, DC Pew Charitable Trusts ( 2012.
  • Kreiner, Peter. "Geospatial analyses of opioid overdose rates and rates of questionable activity in Massachusetts." National Rx Abuse Summit. Orlando, FL. April 10-12, 2012.
  • Kreiner, Peter. "Prescription monitoring programs: An important new area for evaluation and a vastly underutilized data resource." American Evaluation Association Conference. Minneapolis, MN. October 25, 2012.
  • Kreiner, Peter. "Non-medical prescription drug use and market intervention: Prescription drug monitoring program data and law enforcement." National Institutes of Justice Annual Conference. Washington, DC. June 22, 2011.
  • Thomas, C., Kim, M., McDonald, A., Kreiner, P., Kelleher, S., Blackman, M., Kaufman, P., & Carrow, G. "Prescribers’ expectations and barriers to electronic prescribing of controlled substances.." Journal of the American Medical Informatics Association doi:10.1136/amaiamnl-2011-000209. (2011).
  • Katz, N., Panas, L., Kim, M., Audet, A., Bilansky, A., Eadie, J., Kreiner, P., Paillard, F., Thomas, C., & Carrow, G.. "Usefulness of prescription monitoring programs for surveillance – analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006." Pharmacoepidemiology and Drug Safety 19. (2009): 115-123.
  • Katz, N., Houle, B., Fernandez, K., Kreiner, P., Thomas, C., Kim, M., Carrow, G., Audet, A., & Brushwood, D.. "Update on prescription monitoring in clinical practice: A survey study of prescription monitoring program administrators." Pain Medicine 9. 5 (2008): 587-594.
  • Markoff, L., Finkelstein, N., Kammerer, N., Kreiner, P., & Prost, C.. "Relational systems change: Implementing a model of change in integrating services for women with substance abuse and mental health disorders and histories of trauma." Journal of Behavioral Health Services and Research 32. 2 (2005): 227-240.
  • Kreiner, P., Soldz, S., Berger, M., Elliott, E., Reynes, J., Williams, C., & Rodriguez-Howard, M.. "Social indicator-based measures of substance abuse consequences, risk, and protection at the town level." Journal of Primary Prevention 22. 3 (2001): 339-365.
  • Soldz, S., Kreiner, P., Clark, T., & Krakow, M.. "Tobacco use among Massachusetts youth: Is tobacco control working?." Preventive Medicine 31. (2000): 287-295.
  • Kreiner, P. & Bhambri, A.. "Influence and information in organization-stakeholder relationships." Research in Corporate Social Performance and Policy 12. (1991): 3-36.